The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients
Therapeutics and Clinical Risk Management Aug 30, 2017
Liu SH, et al. - This trial determined if the time–averaged serum high–sensitivity CRP (HS–CRP) level was a better predictor of clinical outcomes than a single HS–CRP level, in patients undergoing peritoneal dialysis (PD). The time–averaged serum HS–CRP level served as a better marker than a single baseline measurement in speculating the 5–year mortality and dropout in PD patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
